VoxCell BioInnovation originated from current technology limitations and the gap in the market for creating complex 3D bioprinted models, specifically in the area of tissue engineering and the drug development industry; existing 3D bioprinting technology is not capable of developing human-like models with high resolution and meaningful vasculature.
Accomplishments and partners
VoxCell is grateful to have been awarded grants and to participate in accelerators and incubators, join communities, and partner with these leading organizations
Get in touch
We would love to hear from you regarding partnerships, collaboration, or to chat about the future of Life Sciences. Send us a short message and someone will be in contact soon or follow us on social media.